Lily Z Dai

Title: Innovations of Lily Z Dai

Introduction

Lily Z Dai is a prominent inventor based in Derwood, MD (US). She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of three patents to her name, her work has the potential to impact therapeutic and diagnostic methods in medicine.

Latest Patents

Lily Z Dai's latest patents focus on monoclonal antibodies that bind to poly-γ-D-glutamic acid (γDPGA), which is present on the surface of certain cells. These patents also include chimeric forms of the monoclonal antibodies, humanized forms, and fragments thereof. Additionally, the patents disclose nucleic acids encoding the antibodies and fragments, as well as pharmaceutical compositions that include such antibodies. The disclosed methods provide prophylactic, therapeutic, and diagnostic applications for these antibodies.

Career Highlights

Lily Z Dai is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. Her work at this esteemed institution has allowed her to contribute to groundbreaking research in the field of immunology and therapeutic development.

Collaborations

Some of her notable coworkers include Zhaochun Chen and Robert H Purcell. Their collaborative efforts have further advanced the research and development of innovative medical solutions.

Conclusion

Lily Z Dai's contributions to the field of biotechnology through her patents and research at the National Institutes of Health highlight her role as a leading inventor. Her work continues to pave the way for advancements in medical therapies and diagnostics.